| Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial | |
| Lacroix, A.; Gu, F.; Gallardo, W.; Pivonello, R.; Yu, Y.; Witek, P.; Boscaro, M.; Salvatori, R.; Yamada, M.; Tauchmanova, L. | |
| 刊名 | The Lancet Diabetes and Endocrinology
 |
| 2018 | |
| 卷号 | Vol.6 No.1页码:17-26 |
| ISSN号 | 2213-8587 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/1820847 |
| 专题 | 四川大学 |
| 作者单位 | 1.Chirurgia, Università Federico II di Napoli, Naples, Italy 2.k Novartis, East Hanover, NJ, United States 3.Endocrinology Service, Hospital Guillermo Almenara, Lima, Peru 4.h Division of Endocrinology, Diabetes and Metabolism and Pituitary Center, Johns Hopkins University, Baltimore, MD, United States 5.a Division of Endocrinology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada 6.f Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland 7.Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China 8.Dipartimento di Medicina Clinica 9.n Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom 10.j Novartis, Basel, Switzerland |
| 推荐引用方式 GB/T 7714 | Lacroix, A.,Gu, F.,Gallardo, W.,et al. Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial[J]. The Lancet Diabetes and Endocrinology,2018,Vol.6 No.1:17-26. |
| APA | Lacroix, A..,Gu, F..,Gallardo, W..,Pivonello, R..,Yu, Y..,...&Yamada, S..(2018).Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.The Lancet Diabetes and Endocrinology,Vol.6 No.1,17-26. |
| MLA | Lacroix, A.,et al."Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial".The Lancet Diabetes and Endocrinology Vol.6 No.1(2018):17-26. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论